15.7101.63% ( -0.260 )
Delay Closed: Nov 17, 16:08:15Financials
Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: CONSUN PHARMA(01681) the Revenue is 1.031 B (+19.93%);the EBIT is 383.28 M (+35.89%);the EPS is 0.404 (+27.22%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
1.03B19.93%
----
----
EBIT
0.38B35.89%
----
----
EPS
0.404327.22%
----
----
Upcoming earnings report - FY2026 Q3 Earning Release
Available dateNov 26, 2026
Estimate Revenue--
Estimate EBIT--
Estimate EPS--
Revenue
ActualEstimateUnit: HKD
Quarterly
EBIT
ActualEstimateUnit: HKD
Quarterly
Net income
ActualEstimateUnit: HKD
Quarterly
EPS
ActualEstimateUnit: HKD
Quarterly
